Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The synthetic vasopressin analogue is an injectable medication indicated for patients with hepatorenal syndrome who are experiencing rapid deterioration of kidney function (type 1 hepatorenal syndrome).
Austrian research indicates that it is not overweight status alone but being overweight and having an unfavorable metabolic profile that increases the risk of kidney failure.
August 23, 2022—KOAG LLC, a privately held medical device company based in Minneapolis, Minnesota, announced that its topical vascular closure s
/PRNewswire/ -- KOAG LLC, a Minneapolis-based medical device firm engaged in the design of innovative, topical vascular closure systems, announced today it...
/PRNewswire/ -- KOAG LLC, a Minneapolis-based medical device firm engaged in the design of innovative, topical vascular closure systems, announced today it...